Figure 5.
Figure 5. KGF administration enhances thymopoiesis and peripheral T-cell development in 18-month-old mice. Eighteen-month-old CBA mice received 5 mg/kg KGF or PBS subcutaneously on 3 consecutive days. Mice were harvested 14 days after KGF administration, and thymic and splenic cellularity were determined. (A) Thymic and splenic cellularity are depicted. (B-C) Thymic subpopulations were calculated as described in Figure 1. (D) Splenic T-cell numbers were determined as described in Table 1. (E) Splenocytes were stained with anti-CD4, -CD8, and -CD44 antibodies, and the percentages of T cells (naive CD4, CD4+CD44-; memory CD4, CD4+CD44+; naive CD8, CD8+CD44-; and memory CD8, CD8+CD44+) were determined by multicolor flow cytometry. Values represent mean (± SEM) and n = 4-8 per group. *P < .05.

KGF administration enhances thymopoiesis and peripheral T-cell development in 18-month-old mice. Eighteen-month-old CBA mice received 5 mg/kg KGF or PBS subcutaneously on 3 consecutive days. Mice were harvested 14 days after KGF administration, and thymic and splenic cellularity were determined. (A) Thymic and splenic cellularity are depicted. (B-C) Thymic subpopulations were calculated as described in Figure 1. (D) Splenic T-cell numbers were determined as described in Table 1. (E) Splenocytes were stained with anti-CD4, -CD8, and -CD44 antibodies, and the percentages of T cells (naive CD4, CD4+CD44-; memory CD4, CD4+CD44+; naive CD8, CD8+CD44-; and memory CD8, CD8+CD44+) were determined by multicolor flow cytometry. Values represent mean (± SEM) and n = 4-8 per group. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal